𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progress of the Study of Rho-Kinase and Future Perspective of the Inhibitor

✍ Scribed by Shunsuke Tawara; Hiroaki Shimokawa

Publisher
John Wiley and Sons
Year
2007
Weight
11 KB
Volume
38
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic potential of experimental au
Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor
✍ Jie-Zhong Yu; Jing Ding; Cun-Gen Ma; Chang-Hai Sun; Yi-Fu Sun; Chuan-Zhen Lu; Ba πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 473 KB

## Abstract The migration of aberrant inflammatory cells into the central nervous system plays an important role in the pathogenesis of demyelinating diseases potentially through the Rho/Rho‐kinase (Rock) pathway, but direct evidence from human and animal models remains inadequate. Here we further

Transcriptomic profiling of astrocytes t
Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor Fasudil reveals cytoskeletal and pro-survival responses
✍ Chew L. Lau; Victoria M. Perreau; Minghui J. Chen; Holly S. Cate; Daniel Merlo; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 944 KB

## Abstract Inhibitors of Rho kinase (ROCK) have potential for management of neurological disorders by inhibition of glial scarring. Since astrocytes play key roles in brain physiology and pathology, we determined changes in the astrocytic transcriptome produced by the ROCK inhibitor Fasudil to obt